Search Results

Filter
  • 1-10 of  17,714 results for ""Triple Negative Breast Neoplasms""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

K48-linked deubiquitination of VGLL4 by USP15 enhances the efficacy of tumor immunotherapy in triple-negative breast cancer.

  • Authors : Wang X; Department of Thyroid and Breast Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, 200072, China; Institute of Breast Disease, School of Medicine, Tongji University, China.

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy; Humans

  • Source: Cancer letters [Cancer Lett] 2024 Apr 28; Vol. 588, pp. 216764. Date of Electronic Publication: 2024 Feb 29.Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cyclin-dependent kinase inhibitors enhance programmed cell death protein 1 immune checkpoint blockade efficacy in triple-negative breast cancer by affecting the immune microenvironment.

  • Authors : Wu J; Department of Breast Oncology, Zhejiang Cancer Hospital, Hangzhou, China.; Wang W

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology; Animals

  • Source: Cancer [Cancer] 2024 Apr 15; Vol. 130 (S8), pp. 1449-1463. Date of Electronic Publication: 2024 Mar 14.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer.

  • Authors : Zhang S; School of Life Sciences, Tianjin University, Tianjin, China.; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, China.

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics; Humans

  • Source: Cancer [Cancer] 2024 Apr 15; Vol. 130 (S8), pp. 1415-1423. Date of Electronic Publication: 2023 Dec 11.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142

Record details

×
Academic Journal

Long-term survival after neoadjuvant therapy for triple-negative breast cancer under different treatment regimens: a systematic review and network meta-analysis.

  • Authors : Liu Z; Breast Disease Diagnosis and Treatment Center, Affiliated Hospital of Qinghai University, Affiliated Cancer Hospital of Qinghai University, People's Republic of China, Qinghai Provincial Clinical Research Center for Cancer, Qinghai Provincial Institute of Cancer Research, Xining, China.; Li J

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology; Humans

  • Source: BMC cancer [BMC Cancer] 2024 Apr 09; Vol. 24 (1), pp. 440. Date of Electronic Publication: 2024 Apr 09.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

×
Academic Journal

U2AF2-SNORA68 promotes triple-negative breast cancer stemness through the translocation of RPL23 from nucleoplasm to nucleolus and c-Myc expression.

  • Authors : Zhang W; Department of Breast Surgery, The First Hospital of China Medical University, Shenyang, Liaoning Province, China.; Song X

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology; Humans

  • Source: Breast cancer research : BCR [Breast Cancer Res] 2024 Apr 09; Vol. 26 (1), pp. 60. Date of Electronic Publication: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Heat shock factor 1 inhibition enhances the effects of modulated electro hyperthermia in a triple negative breast cancer mouse model.

  • Authors : Viana PHL; Institute of Translational Medicine, Semmelweis University, Tűzoltó Utca 37-47, Budapest, 1094, Hungary.; Schvarcz CA

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/therapy ; Hyperthermia, Induced*

  • Source: Scientific reports [Sci Rep] 2024 Apr 08; Vol. 14 (1), pp. 8241. Date of Electronic Publication: 2024 Apr 08.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Highly Efficient Photoswitchable Smart Polymeric Nanovehicle for Gene and Anticancer Drug Delivery in Triple-Negative Breast Cancer.

  • Authors : Patra R; Gene Therapy and Tissue Engineering Lab, Department of Polymer Science and Technology, University of Calcutta, 92, A.P.C. Road, Kolkata 700009, India.; Halder S

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/pharmacology

  • Source: ACS biomaterials science & engineering [ACS Biomater Sci Eng] 2024 Apr 08; Vol. 10 (4), pp. 2299-2323. Date of Electronic Publication: 2024 Mar 29.Publisher: American Chemical Society Country of Publication: United States NLM ID: 101654670 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence.

  • Authors : Sunassee ED; Department of Biomedical Engineering, Duke University, Durham, NC, USA.; Deutsch RJ

Subjects: Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/pathology

  • Source: Science advances [Sci Adv] 2024 Apr 05; Vol. 10 (14), pp. eadj7540. Date of Electronic Publication: 2024 Apr 05.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

×
Academic Journal

SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.

  • Authors : Deng L; Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai 200032, China.; Liao L

Subjects: Cisplatin*/Cisplatin*/Cisplatin*/pharmacology ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/drug therapy ; Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/Triple Negative Breast Neoplasms*/genetics

  • Source: Science advances [Sci Adv] 2024 Apr 05; Vol. 10 (14), pp. eadj4009. Date of Electronic Publication: 2024 Apr 03.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic

Record details

×
Academic Journal

Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis.

  • Authors : Bahrin NWS; Pengiran Anak Puteri Rashidah Sa'adatul Bolkiah (PAPRSB) Institute of Health Sciences, Universiti Brunei Darussalam, Jalan Tungku Link, Gadong, BE1410, Negara Brunei Darussalam.; Matusin SNI

Subjects: Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/drug therapy ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/genetics ; Breast Neoplasms*/Breast Neoplasms*/Breast Neoplasms*/metabolism

  • Source: Systematic reviews [Syst Rev] 2024 Apr 04; Vol. 13 (1), pp. 100. Date of Electronic Publication: 2024 Apr 04.Publisher: BioMed Central Country of Publication: England NLM ID: 101580575 Publication Model: Electronic Cited Medium: Internet ISSN: 2046-4053

Record details

×
  • 1-10 of  17,714 results for ""Triple Negative Breast Neoplasms""